Grayson Baldy

#CME Educational Program Director @PeerView
Tweets are my own.

[FdtnForWomensCancer @GYNCancer]

How are antibody-drug conjugates reshaping gynecologic cancer care? Join @PeerView at #ASCO26 on 5/29, 7 PM CDT for a live symposium with @DrKatyMoore & faculty on the latest data and practical strategies for safe, effective use. Register: https://t.co/V9xHCnACiH #Oncology #MedEd

[HopeForStomachCancer @StoCANcer]

Gastric & GEJ cancer treatment is evolving fast and patients deserve care that reflects it. Join us and @PeerView at #ASCO26 for a live symposium on biomarker-driven care, targeted therapies, and immunotherapy. 5/30 at 7 PM CDT in Chicago or virtually. https://t.co/w69Qlo1WPb

[HealthTree Foundation @HealthTree]

Excited to partner with @PeerView to bring the MoD Squad to #ASCO26! Join Drs. @SagarLonialMD, Nizar Bahlis, & @DrKrinaPatel on 5/29 at 7 PM CDT to explore
#CELMoDs in #MultipleMyeloma.
Join us live in Chicago or virtually: https://t.co/Fl3rSFiD8d

[PeerView @PeerView]

Dr. Sabari (@JSabari) invites you to join him alongside Drs. Leighl & Jänne at #ASCO26 for a PeerView live symposium on EGFRm #NSCLC focused on treatment sequencing, resistance management & optimizing patient care #MedEd

📅 5/30 at 7 PM CDT
📍 Chicago + Virtual
🔗 https://t.co/W9BIMWXwFJ

[PeerView @PeerView]

Dr. Goldman invites you to join him alongside Dr. Camidge (@DRCamidge) & Dr. Le (@LeXiuning) at #ASCO26 for a PeerView live symposium on MET-altered #NSCLC, focused on biomarker testing, MET-targeted therapies & personalized treatment strategies: https://t.co/hjMuooDcVD #MedEd

[PeerView @PeerView]

How are emerging therapies changing #HNSCC care? Join Prof. Harrington and Drs. Burtness and Bhatia (@AartiBhatiaMD) at #ASCO26 for a PeerView Live symposium on immunotherapy, bispecific antibodies, and evolving treatment strategies in HNSCC: https://t.co/IeNOhggtxx #MedEd @YaleCancer

[PeerView @PeerView]

Dr. Morgans (@CapSurvivorship) invites you to join her and Drs. Armstrong (@AarmstrongDuke) and Heath during their session, Continuing the Innovation Story in #ProstateCancer, happening during #ASCO26 on 5/29—in Chicago and virtually: https://t.co/BBPXIdAKg0

In partnership with Prostate Net (@vhsimons) #MedEd

[Tarik Sammour @tarik_sammour]

Looking forward to this!
9:30am Saturday, May 30th Adelaide time.

@PeerView @cathengMD @mgfakih #ASCO26 #MedEd
https://t.co/zzcBxAOpPX

[Dr. Marwan G. Fakih @mgfakih]

This will be an exciting session on Friday, May 29th, in Chicago--- First day of ASCO meeting. Please join us if you can!

[HOPARX @HOPArx]

Still need CE credits after #HOPA2026? Check out these Post-Annual Conference Virtual Symposia by @PeerView Institute for Medical Education. The first symposium, on JAKi Therapy, takes place today @ 7PM EDT, so don't miss out! https://t.co/eUxNPkCwZP

[Jen Silverman @SpeakJen]

Level up #Hemophilia care with gene therapy! 💉

Join @PeerView with expert faculty Drs. @GuyYoungMD & Mark Reding at #THSNA2026 in Portland, 3/21 6:45 AM PDT.

Dynamic cases ✅ Practical strategies ✅ Real-world impact ✅ Game-changing insights ✅

🔗https://t.co/1arbbjqN3z

[Guy Young @GuyYoungMD]

I’m looking forward to joining Dr. Reding at #THSNA2026 to discuss the evolving role of gene therapy in hemophilia B, including patient selection, counseling, and practical delivery considerations in real-world care. Join us 3/21 at 6:45 AM PDT in Portland or virtually on 3/30.

[Kidney Cancer @KidneyCancer]

What’s next in advanced #RCC?

Learn how approved IO combinations and emerging approaches are shaping care across disease stages with @montypal @PBarataMD @crisuarez08 on 2/26 at 7:00 PM PST at #GU26 🔗 https://t.co/dUHhcL1l9X

In partnership with @PeerView #Oncology #Urology

[Jen Silverman @SpeakJen]

The RCC playbook is changing — are you?
🚨 #Oncology & #KidneyCancer clinicians — don’t miss this! 🚨

Turn today’s data into real-world #RCC care with @PeerView + @KidneyCancer at #GU26.

💬 @montypal | @PBarataMD | @crisuarez08
🗓️ 2/26 | ⏰ 7 PM PST | 🔗https://t.co/vLy0DSqhxM

[Pedro C Barata, MD MSc FACP @PBarataMD]

Want to stay ahead in #RCC care? Join me, @montypal, and @crisuarez08 live San Fran or online 2/26 at 7:00 PM PST for Unlocking the Potential of Modern RCC Therapies. Discover practical strategies to tailor tx & improve outcomes:
https://t.co/x2bjESluVq @PeerView @KidneyCancer

[Blue Faery @BlueFaeryLiver]

Happy New Year! Ready to strengthen your #HCC care strategy? Join our live & virtual symposium on 1/8 at 7 PM PST during #GI26 with @PeerView
Gain insights into sequencing strategies, multidirectional regimens & real-world clinical decision-making. Register: https://t.co/C2DI72rY0R
#liverhealth #livercancer #liverdisease #oncology

[PeerView @PeerView]

Hear from @DianeReidyLagun as she invites you to a live, in-person & virtual symposium during #ASCOGI on 1/8 at 7:15 PM PST, exploring how evolving evidence is shaping care for neuroendocrine neoplasms with Simron Singh, MD, MPH and @Ja_Capdevila.

🔗 https://t.co/0RMSx9SkyG
#MedEd #Oncology

[PeerView @PeerView]

How are experts approaching selection and sequencing of innovative immunotherapy and targeted platforms in #HCC? Join Prof. Dr. Peter R. Galle, @DrElkhoueiry and Dr. Robin Kelley for a live Seminars & Tumor Board–style symposium during #GI26 #oncology #livercancer

🗓 1/8 | 7 PM PST
🔗 https://t.co/BwBJsONP2X

[PeerView @PeerView]

Join us live in person or virtually at #ASCOGI: A case-based discussion on evolving systemic therapy strategies and guideline-driven care for neuroendocrine neoplasms. Produced with @NCAN #NENs #MedEd

📍 1/8 at 7 PM PST
Register: https://t.co/jYqaZ1JqeI

[Grayson Baldy @graysonrbaldy]

It’s an exciting evening in Honolulu at #SNO2025 ✨
If you’re attending in person, come join us at 5:30 PM HST for a dynamic MasterClass on IDH-mutant glioma with Drs. Ahluwalia (@BRAINTUMORDOC) & Cloughesy. We can’t wait to learn with you!

[PeerView @PeerView]

Aloha from PeerView! 🌺

Head to the Hilton Hawaiian Village tonight at 5:45 PM HST (10:45 PM EST) for our MasterClass on IDH-mutant glioma during #SNO2025! Join Drs. Ahluwalia & Cloughesy for expert insights #MedEd #Oncology #PeerView @theABTA

Register: https://t.co/UMjsfoQVP2